These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
245 related articles for article (PubMed ID: 14609992)
1. "No turning back" on cheap AIDS drugs for poor nations, UN vows. Silversides A CMAJ; 2003 Nov; 169(10):1067. PubMed ID: 14609992 [No Abstract] [Full Text] [Related]
2. Cheap HIV drugs for developing countries. Int J Epidemiol; 2001 Jun; 30(3):651-2. PubMed ID: 11460820 [No Abstract] [Full Text] [Related]
3. World Trade Organization still threatens supply of affordable AIDS drugs. Hagmann M Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300 [No Abstract] [Full Text] [Related]
4. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity. Berger JM Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292 [No Abstract] [Full Text] [Related]
5. Indian company seeks US approval for generic AIDS drugs. Nature; 2004 Aug; 430(7001):716. PubMed ID: 15306779 [No Abstract] [Full Text] [Related]
7. Less expensive ZDV on the way. AIDS Read; 2005 Nov; 15(11):573-4. PubMed ID: 16329175 [No Abstract] [Full Text] [Related]
8. Canada's plan to sell generic drugs to developing countries is threatened. Spurgeon D BMJ; 2004 Mar; 328(7442):728. PubMed ID: 15044278 [No Abstract] [Full Text] [Related]
9. Access to treatment for HIV/AIDS: a human rights issue in the developing world. Joni J Conn J Int Law; 2002; 17(2):273-80. PubMed ID: 12688296 [No Abstract] [Full Text] [Related]
10. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after. Cohen J Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654 [No Abstract] [Full Text] [Related]
11. Closing the affordability gap for drugs in low-income countries. Steinbrook R N Engl J Med; 2007 Nov; 357(20):1996-9. PubMed ID: 18003957 [No Abstract] [Full Text] [Related]
12. Commentary: the reality of treating HIV and AIDS in poor countries. Sykes R BMJ; 2002 Jan; 324(7331):216-7. PubMed ID: 11831203 [No Abstract] [Full Text] [Related]
13. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges. Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289 [No Abstract] [Full Text] [Related]
14. Companies reduce prices for HIV drugs in developing countries. Gottlieb S Bull World Health Organ; 2000; 78(6):862. PubMed ID: 10916926 [TBL] [Abstract][Full Text] [Related]
15. Just the medicine. Cheaper AIDS drugs. Whitelaw K US News World Rep; 2001 Mar; 130(12):31. PubMed ID: 11277041 [No Abstract] [Full Text] [Related]
16. A one-time-only combination: Emergency medicine exports and the TRIPS agreement under Canada's access to medicines regime. Weber A; Mills L Health Hum Rights; 2010 Jun; 12(1):109-22. PubMed ID: 20930258 [TBL] [Abstract][Full Text] [Related]
17. Action alert: drug-patent bill could cost patients $3 billion+; hearing July 1. AIDS Treat News; 1999 Jun; (No 321):8. PubMed ID: 11366716 [TBL] [Abstract][Full Text] [Related]
18. Drug makers to cut prices for developing countries. AIDS Alert; 1998 Aug; 13(8 Suppl):1-2. PubMed ID: 11365655 [TBL] [Abstract][Full Text] [Related]
19. GlaxoSmithKline, under pressure, cuts price of AIDS treatment for poor countries. Fleck F Bull World Health Organ; 2003; 81(6):469. PubMed ID: 12894339 [No Abstract] [Full Text] [Related]
20. AIDS research. Drug trials without the drugs? Cohen J Science; 2003 May; 300(5623):1212-3. PubMed ID: 12764159 [No Abstract] [Full Text] [Related] [Next] [New Search]